EP2077276A1
(en)
*
|
2000-06-23 |
2009-07-08 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of disorders involving angiogensis
|
US20030114410A1
(en)
|
2000-08-08 |
2003-06-19 |
Technion Research And Development Foundation Ltd. |
Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
|
US7164009B2
(en)
|
2000-09-15 |
2007-01-16 |
Genentech, Inc. |
Pro9821 polypeptides
|
JP2005516579A
(en)
|
2000-12-08 |
2005-06-09 |
キュラジェン コーポレイション |
Methods for detecting and treating nodular sclerosis complex associated with injury
|
US20060035237A1
(en)
*
|
2002-08-26 |
2006-02-16 |
Markowitz Sanford D |
Methods and compositions for categorizing patients
|
US7271240B2
(en)
|
2001-03-14 |
2007-09-18 |
Agensys, Inc. |
125P5C8: a tissue specific protein highly expressed in various cancers
|
WO2002098356A2
(en)
*
|
2001-06-05 |
2002-12-12 |
Exelixis Inc. |
Ppp2cs as modifiers of the p53 pathway and methods of use
|
WO2003029273A2
(en)
*
|
2001-09-28 |
2003-04-10 |
Whitehead Institute For Biomedical Research |
Classification of lung carcinomas using gene expression analysis
|
WO2003054512A2
(en)
*
|
2001-12-20 |
2003-07-03 |
Tularik Inc. |
Identification of an amplified gene and target for drug intervention
|
EP1361433A3
(en)
*
|
2002-04-09 |
2005-02-23 |
Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo |
Method for estimating therapeutic efficacy of tumor necrosis factor (TNF)
|
DE10225144A1
(en)
*
|
2002-05-29 |
2003-12-18 |
Immatics Biotechnologies Gmbh |
Tumor-associated peptides binding to MHC molecules
|
US20060189518A1
(en)
*
|
2002-06-26 |
2006-08-24 |
Takeda Pharmaceutical Company Limited |
Preventing/remedies for cancer
|
GB0215224D0
(en)
*
|
2002-07-01 |
2002-08-14 |
Inpharmatica Ltd |
Protein
|
US7803370B2
(en)
|
2002-08-30 |
2010-09-28 |
Oncotherapy Science, Inc. |
Method for treating synovial sarcoma
|
AU2003256079A1
(en)
*
|
2002-08-30 |
2004-03-19 |
Japan As Represented By President Of The University Of Tokyo |
Method for treating synovial sarcoma
|
AU2003268494A1
(en)
*
|
2002-09-11 |
2004-04-30 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
TW200413725A
(en)
*
|
2002-09-30 |
2004-08-01 |
Oncotherapy Science Inc |
Method for diagnosing non-small cell lung cancers
|
EP1573069A4
(en)
*
|
2002-12-20 |
2006-06-07 |
Avalon Pharmaceuticals |
Amplified cancer target genes useful in diagnosis and therapeutic screening
|
US20060104981A1
(en)
*
|
2002-12-24 |
2006-05-18 |
Yuichi Hikichi |
Prophylactic/therapeutic agent for cancer
|
EP1577322A4
(en)
*
|
2002-12-26 |
2006-01-25 |
Takeda Pharmaceutical |
Novel proteins and use thereof
|
CA2517802A1
(en)
*
|
2003-03-03 |
2004-09-16 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Protein tyrosine phosphatase-prl-1 a a marker and therapeutic target for pancreatic cancer
|
NZ542490A
(en)
*
|
2003-03-11 |
2008-04-30 |
Univ British Columbia |
Diagnosis of gynecological neoplasms by detecting the levels of oviduct-specific glycoprotein
|
CA2520512A1
(en)
*
|
2003-03-24 |
2004-10-07 |
Corixa Corporation |
Methods, compositions and kits for the detection and monitoring of lung cancer
|
AU2003901511A0
(en)
*
|
2003-03-28 |
2003-04-17 |
Bionomics Limited |
Nucleic acid molecules associated with angiogenesis II
|
US20060216286A1
(en)
|
2003-04-25 |
2006-09-28 |
Yasuaki Ito |
Novel screening method
|
WO2004097034A2
(en)
*
|
2003-05-02 |
2004-11-11 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with human transmembrane serine protease 4 (tmprss4)
|
CA3084542A1
(en)
*
|
2003-06-10 |
2005-01-06 |
The Trustees Of Boston University |
Gene expression analysis of airway epithelial cells for diagnosing lung cancer
|
WO2004111197A2
(en)
*
|
2003-06-10 |
2004-12-23 |
Trustees Of Boston University |
Gene expression signatures, methods and compositions for diagnosing disorders of the lung
|
WO2005002417A2
(en)
*
|
2003-06-20 |
2005-01-13 |
Avalon Pharmaceuticals, Inc. |
Cancer -linked gene aas target for chemotherapy
|
ES2481672T3
(en)
*
|
2003-07-17 |
2014-07-31 |
Pacific Edge Limited |
Markers for gastric cancer detection
|
KR101520209B1
(en)
|
2003-11-06 |
2015-05-13 |
시애틀 지네틱스, 인크. |
Monomethylvaline compounds capable of conjugation to ligands
|
WO2005059109A2
(en)
*
|
2003-12-15 |
2005-06-30 |
The Regents Of The University Of California |
Molecular signature of the pten tumor suppressor
|
WO2006131783A2
(en)
*
|
2004-01-27 |
2006-12-14 |
Compugen Usa, Inc. |
Polynucleotides, polypeptides, and diagnosing lung cancer
|
EP1584684A1
(en)
*
|
2004-02-20 |
2005-10-12 |
Samsung Electronics Co., Ltd. |
Breast cancer related protein, gene encoding the same, and method of diagnosing breast cancer using the protein and gene
|
US20050186577A1
(en)
|
2004-02-20 |
2005-08-25 |
Yixin Wang |
Breast cancer prognostics
|
US7399469B2
(en)
*
|
2004-03-26 |
2008-07-15 |
Pdl Biopharma, Inc. |
Anti-LFL2 antibodies for the diagnosis, prognosis and treatment of cancer
|
JP2005314397A
(en)
*
|
2004-03-31 |
2005-11-10 |
Mitsubishi Chemicals Corp |
Anti-chondromodulin-1-specific antibody and its use
|
EP1743944A4
(en)
|
2004-04-23 |
2011-01-05 |
Takeda Pharmaceutical |
Novel method of screening
|
DE102004023187A1
(en)
|
2004-05-11 |
2005-12-01 |
Ganymed Pharmaceuticals Ag |
Identification of surface-associated antigens for tumor diagnosis and therapy
|
NZ551180A
(en)
|
2004-06-01 |
2009-10-30 |
Genentech Inc |
Antibody drug conjugates and methods
|
DE602005020786D1
(en)
|
2004-06-03 |
2010-06-02 |
Takeda Pharmaceutical |
NEW PROTEIN COMPLEX AND APPLICATIONS THEREOF
|
US20110177079A1
(en)
*
|
2004-09-08 |
2011-07-21 |
Ludwig Institute For Cancer Research |
Cancer-testis antigens
|
EP1791565B1
(en)
|
2004-09-23 |
2016-04-20 |
Genentech, Inc. |
Cysteine engineered antibodies and conjugates
|
US20100111856A1
(en)
|
2004-09-23 |
2010-05-06 |
Herman Gill |
Zirconium-radiolabeled, cysteine engineered antibody conjugates
|
US8034578B2
(en)
*
|
2004-10-19 |
2011-10-11 |
Oncotherapy Science, Inc. |
PKP3 oncogene as a prognostic indicator for lung cancer
|
US20090208938A1
(en)
*
|
2005-02-10 |
2009-08-20 |
Centre National De La Recherche Scientifique |
Use of the MCM8 Gene for the Preparation of a Pharmaceutical Composition
|
PL2325306T3
(en)
*
|
2005-02-25 |
2014-07-31 |
Oncotherapy Science Inc |
Peptide vaccines for lung cancers expressing TTK, URLC10 or KOC1 polypeptides
|
DE102005013846A1
(en)
|
2005-03-24 |
2006-10-05 |
Ganymed Pharmaceuticals Ag |
Identification of surface-associated antigens for tumor diagnosis and therapy
|
EP2360278A1
(en)
|
2005-04-14 |
2011-08-24 |
Trustees Of Boston University |
Diagnostic for lung disorders using class prediction
|
GB0508863D0
(en)
*
|
2005-04-29 |
2005-06-08 |
Astrazeneca Ab |
Peptide
|
US8147838B2
(en)
*
|
2005-05-13 |
2012-04-03 |
Oxford Biomedica (Uk) Limited |
Peptide
|
DK1957539T3
(en)
|
2005-12-08 |
2013-05-06 |
Medarex Inc |
HUMAN MONOCLONAL ANTIBODIES FOR PROTEINTYROSINKINASE 7 (PTK7) AND THEIR USE
|
GB0526498D0
(en)
*
|
2005-12-28 |
2006-02-08 |
Randox Lab Ltd |
Method
|
ES2544957T3
(en)
|
2006-03-21 |
2015-09-07 |
Genentech, Inc. |
Combined therapy involving alpha5beta1 antagonists
|
JP5114637B2
(en)
*
|
2006-03-31 |
2013-01-09 |
静岡県 |
Determination method of small cell lung cancer
|
JP5298266B2
(en)
*
|
2006-03-31 |
2013-09-25 |
静岡県 |
Evaluation kit for small cell lung cancer
|
EP2044123B1
(en)
|
2006-06-21 |
2013-03-13 |
Oncotherapy Science, Inc. |
Tumor-targeting monoclonal antibodies to fzd10 and uses thereof
|
CA2655933C
(en)
*
|
2006-06-23 |
2014-09-09 |
Alethia Biotherapeutics Inc. |
Polynucleotides and polypeptide sequences involved in cancer
|
WO2008020586A1
(en)
|
2006-08-14 |
2008-02-21 |
Forerunner Pharma Research Co., Ltd. |
Diagnosis and treatment of cancer using anti-desmoglein-3 antibody
|
EP1932854A1
(en)
*
|
2006-12-15 |
2008-06-18 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Lysosomal associated membrane protein (LAMP) - like polypeptide, ligands to the same, and use of the same in the frame of detection and purification of human plasmacytoid dendritic cells
|
TWI438207B
(en)
|
2007-02-21 |
2014-05-21 |
Oncotherapy Science Inc |
Peptide vaccines for cancers expressing tumor-associated antigens
|
CA2686954A1
(en)
*
|
2007-05-08 |
2008-11-20 |
Picobella Llc |
Methods for diagnosing and treating prostate and lung cancer
|
US20100183514A1
(en)
|
2007-05-29 |
2010-07-22 |
President And Fellows Of Harvard College |
Molecules involved in regulation of osteoblast activity and osteoclast activity, and methods of use thereof
|
JP5659014B2
(en)
|
2007-08-02 |
2015-01-28 |
ジリード バイオロジクス,インク. |
Methods and compositions for treatment and diagnosis of fibrosis, tumor invasion, angiogenesis and metastasis
|
AU2008290060B2
(en)
|
2007-08-20 |
2014-04-24 |
Oncotherapy Science, Inc. |
CDH3 peptide and medicinal agent comprising the same
|
KR20100075858A
(en)
*
|
2007-08-24 |
2010-07-05 |
온코세라피 사이언스 가부시키가이샤 |
Cancer-related genes, cdca5, epha7, stk31 and wdhd1
|
AU2008296927C1
(en)
*
|
2007-09-06 |
2015-08-13 |
Case Western Reserve University |
Methods for diagnosing and treating cancers
|
WO2009039457A1
(en)
|
2007-09-19 |
2009-03-26 |
The Trustees Of Boston University |
Identification of novel pathways for drug development for lung disease
|
SI2200700T1
(en)
|
2007-09-26 |
2016-04-29 |
Genentech, Inc. |
Novel antibodies
|
AU2009270988A1
(en)
|
2008-07-15 |
2010-01-21 |
Genentech, Inc. |
Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds
|
TW201008574A
(en)
|
2008-08-19 |
2010-03-01 |
Oncotherapy Science Inc |
INHBB epitope peptides and vaccines containing the same
|
US10359425B2
(en)
|
2008-09-09 |
2019-07-23 |
Somalogic, Inc. |
Lung cancer biomarkers and uses thereof
|
GB2478441B
(en)
*
|
2008-09-09 |
2013-03-27 |
Somalogic Inc |
Lung cancer biomarkers and uses thereof
|
US9290556B2
(en)
|
2008-09-29 |
2016-03-22 |
The Trustees Of The University Of Pennsylvania |
Tumor vascular marker-targeted vaccines
|
UA102274C2
(en)
|
2008-10-22 |
2013-06-25 |
Онкотерапі Саєнс, Інк. |
Epitope peptid rab6kifl/kif20a and vaccines containing it
|
EP2362905A4
(en)
*
|
2008-10-24 |
2012-07-04 |
Oncotherapy Science Inc |
Screening method of anti-lung or esophageal cancer compounds
|
CN102245773B
(en)
|
2008-11-03 |
2014-08-27 |
阿莱斯亚生物疗法股份有限公司 |
Antibodies that specifically block the biological activity of a tumor antigen
|
US9495515B1
(en)
|
2009-12-09 |
2016-11-15 |
Veracyte, Inc. |
Algorithms for disease diagnostics
|
US9107935B2
(en)
|
2009-01-06 |
2015-08-18 |
Gilead Biologics, Inc. |
Chemotherapeutic methods and compositions
|
JP5800299B2
(en)
*
|
2009-02-20 |
2015-10-28 |
国立大学法人 東京大学 |
Novel monoclonal antibody and use thereof
|
NZ594343A
(en)
|
2009-03-25 |
2013-10-25 |
Genentech Inc |
Novel anti-alpha5beta1 antibodies and uses thereof
|
TW201102081A
(en)
|
2009-05-11 |
2011-01-16 |
Oncotherapy Science Inc |
TTK peptides and vaccines including the same
|
SG2014004816A
(en)
|
2009-08-21 |
2014-03-28 |
Gilead Biologics Inc |
Catalytic domains from lysyl oxidase and loxl2
|
JP2013504585A
(en)
|
2009-09-09 |
2013-02-07 |
セントローズ, エルエルシー |
Extracellular targeted drug complex
|
WO2011051271A2
(en)
|
2009-10-26 |
2011-05-05 |
Externautics S.P.A. |
Prostate tumor markers and methods of use thereof
|
WO2011051278A1
(en)
*
|
2009-10-26 |
2011-05-05 |
Externautics S.P.A. |
Lung tumor markers and methods of use thereof
|
US10288617B2
(en)
|
2009-10-26 |
2019-05-14 |
Externautics Spa |
Ovary tumor markers and methods of use thereof
|
WO2011088163A1
(en)
|
2010-01-14 |
2011-07-21 |
President And Fellows Of Harvard College |
Methods for modulating skeletal remodeling and patterning by modulating shn2 activity, shn3 activity, or shn2 and shn3 activity in combination
|
KR101738203B1
(en)
|
2010-04-15 |
2017-05-19 |
메디뮨 리미티드 |
Pyrrolobenzodiazepines and conjugates thereof
|
CA3220104A1
(en)
|
2010-06-08 |
2011-12-15 |
Genentech, Inc. |
Cysteine engineered antibodies and conjugates
|
SG186953A1
(en)
*
|
2010-07-09 |
2013-02-28 |
Somalogic Inc |
Lung cancer biomarkers and uses thereof
|
CN106198980B
(en)
|
2010-08-13 |
2018-09-07 |
私募蛋白质体公司 |
Cancer of pancreas biomarker and application thereof
|
PT2621526T
(en)
|
2010-09-29 |
2018-08-02 |
Seattle Genetics Inc |
Antibody drug conjugates (adc) that bind to 191p4d12 proteins
|
US20120121615A1
(en)
|
2010-11-17 |
2012-05-17 |
Flygare John A |
Alaninyl maytansinol antibody conjugates
|
RS59080B1
(en)
|
2011-03-31 |
2019-09-30 |
Adc Therapeutics Sa |
Antibodies against kidney associated antigen 1 and antigen binding fragments thereof
|
JP5987053B2
(en)
|
2011-05-12 |
2016-09-06 |
ジェネンテック, インコーポレイテッド |
Multiple reaction monitoring LC-MS / MS method for detecting therapeutic antibodies in animal samples using framework signature peptides
|
EP2750713B1
(en)
|
2011-10-14 |
2015-09-16 |
Spirogen Sàrl |
Pyrrolobenzodiazepines and conjugates thereof
|
US20170174753A1
(en)
|
2012-01-09 |
2017-06-22 |
Alethia Biotherapeutics Inc. |
Method for treating breast cancer
|
WO2013130093A1
(en)
|
2012-03-02 |
2013-09-06 |
Genentech, Inc. |
Biomarkers for treatment with anti-tubulin chemotherapeutic compounds
|
SI2906253T1
(en)
|
2012-10-12 |
2018-11-30 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine - anti-psma antibody conjugates
|
HUE045435T2
(en)
|
2012-10-12 |
2019-12-30 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
ES2680153T3
(en)
|
2012-10-12 |
2018-09-04 |
Adc Therapeutics Sa |
Anti-PSMA-pyrrolobenzodiazepine antibody conjugates
|
HUE042731T2
(en)
|
2012-10-12 |
2019-07-29 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-antibody conjugates
|
BR112015008238A2
(en)
|
2012-10-12 |
2017-11-28 |
Adc Therapeutics Sarl |
pyrrolbenzodiazepine-anti-cd22 antibody conjugates
|
WO2014057120A1
(en)
|
2012-10-12 |
2014-04-17 |
Adc Therapeutics Sàrl |
Pyrrolobenzodiazepine-antibody conjugates
|
AU2013328625B2
(en)
|
2012-10-12 |
2016-12-15 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-antibody conjugates
|
JP6307519B2
(en)
|
2012-12-21 |
2018-04-04 |
メドイミューン・リミテッドMedImmune Limited |
Pyrrolobenzodiazepine and its conjugates
|
EA032986B1
(en)
|
2012-12-21 |
2019-08-30 |
Медимьюн Лимитед |
Pyrrolobenzodiazepines
|
EA027910B1
(en)
|
2013-03-13 |
2017-09-29 |
Медимьюн Лимитед |
Pyrrolobenzodiazepines and conjugates thereof
|
CA2905181C
(en)
|
2013-03-13 |
2020-06-02 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof for providing targeted therapy
|
JP6340019B2
(en)
|
2013-03-13 |
2018-06-06 |
メドイミューン・リミテッドMedImmune Limited |
Pyrrolobenzodiazepine and its conjugates
|
EP3626308A1
(en)
|
2013-03-14 |
2020-03-25 |
Veracyte, Inc. |
Methods for evaluating copd status
|
MX2016001862A
(en)
|
2013-08-12 |
2016-08-03 |
Genentech Inc |
1-(chloromethyl)-2,3-dihydro-1h-benzo[e]indole dimer antibody-drug conjugate compounds, and methods of use and treatment.
|
WO2015052534A1
(en)
|
2013-10-11 |
2015-04-16 |
Spirogen Sàrl |
Pyrrolobenzodiazepine-antibody conjugates
|
EP3054983B1
(en)
|
2013-10-11 |
2019-03-20 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
GB201317982D0
(en)
|
2013-10-11 |
2013-11-27 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
US9956299B2
(en)
|
2013-10-11 |
2018-05-01 |
Medimmune Limited |
Pyrrolobenzodiazepine—antibody conjugates
|
EP3082875B1
(en)
|
2013-12-16 |
2020-11-25 |
Genentech, Inc. |
Peptidomimetic compounds and antibody-drug conjugates thereof
|
JP6980384B2
(en)
|
2013-12-16 |
2021-12-15 |
ジェネンテック, インコーポレイテッド |
1- (Chloromethyl) -2,3-dihydro-1H-benzo [E] indole dimer antibody-drug conjugate compound, and methods of use and treatment
|
RU2689388C1
(en)
|
2013-12-16 |
2019-05-28 |
Дженентек, Инк. |
Peptidomimetic compounds and their conjugates of antibodies with drugs
|
US10188746B2
(en)
|
2014-09-10 |
2019-01-29 |
Medimmune Limited |
Pyrrolobenzodiazepines and conjugates thereof
|
GB201416112D0
(en)
|
2014-09-12 |
2014-10-29 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
CA2957354A1
(en)
|
2014-09-12 |
2016-03-17 |
Genentech, Inc. |
Cysteine engineered antibodies and conjugates
|
EP3191134B1
(en)
|
2014-09-12 |
2019-11-20 |
Genentech, Inc. |
Anthracycline disulfide intermediates, antibody-drug conjugates and methods
|
MX2017003523A
(en)
|
2014-09-17 |
2017-11-08 |
Genentech Inc |
Pyrrolobenzodiazepines and antibody disulfide conjugates thereof.
|
US20170335396A1
(en)
|
2014-11-05 |
2017-11-23 |
Veracyte, Inc. |
Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional data
|
CN107148285B
(en)
|
2014-11-25 |
2022-01-04 |
Adc治疗股份有限公司 |
Pyrrolobenzodiazepine-antibody conjugates
|
EP3226909A1
(en)
|
2014-12-03 |
2017-10-11 |
Genentech, Inc. |
Quaternary amine compounds and antibody-drug conjugates thereof
|
GB201505305D0
(en)
|
2015-03-27 |
2015-05-13 |
Immatics Biotechnologies Gmbh |
Novel Peptides and combination of peptides for use in immunotherapy against various tumors
|
LT3388075T
(en)
|
2015-03-27 |
2023-11-10 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against various tumors (seq id 25 - mrax5-003)
|
GB201506411D0
(en)
|
2015-04-15 |
2015-05-27 |
Bergenbio As |
Humanized anti-axl antibodies
|
GB201506402D0
(en)
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
MA43345A
(en)
|
2015-10-02 |
2018-08-08 |
Hoffmann La Roche |
PYRROLOBENZODIAZEPINE ANTIBODY-DRUG CONJUGATES AND METHODS OF USE
|
MA43354A
(en)
|
2015-10-16 |
2018-08-22 |
Genentech Inc |
CONJUGATE DRUG CONJUGATES WITH CLOUDY DISULPHIDE
|
MA45326A
(en)
|
2015-10-20 |
2018-08-29 |
Genentech Inc |
CALICHEAMICIN-ANTIBODY-DRUG CONJUGATES AND METHODS OF USE
|
GB201601431D0
(en)
|
2016-01-26 |
2016-03-09 |
Medimmune Ltd |
Pyrrolobenzodiazepines
|
GB201602356D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
GB201602359D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
GB201603568D0
(en)
*
|
2016-03-01 |
2016-04-13 |
Immatics Biotechnologies Gmbh |
Efficient treatment options including peptides and combination of peptide and cell based medicaments for use in immunotherapy against urinary bladder cancer
|
JP6943872B2
(en)
|
2016-03-25 |
2021-10-06 |
ジェネンテック, インコーポレイテッド |
Multiple whole antibody and antibody complex drug quantification assay
|
GB201607478D0
(en)
|
2016-04-29 |
2016-06-15 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
WO2017201449A1
(en)
|
2016-05-20 |
2017-11-23 |
Genentech, Inc. |
Protac antibody conjugates and methods of use
|
JP7022080B2
(en)
|
2016-05-27 |
2022-02-17 |
ジェネンテック, インコーポレイテッド |
Biochemical analytical methods for the characterization of site-specific antibody-drug conjugates
|
EP3464280B1
(en)
|
2016-06-06 |
2021-10-06 |
F. Hoffmann-La Roche AG |
Silvestrol antibody-drug conjugates and methods of use
|
US10927417B2
(en)
|
2016-07-08 |
2021-02-23 |
Trustees Of Boston University |
Gene expression-based biomarker for the detection and monitoring of bronchial premalignant lesions
|
WO2018031662A1
(en)
|
2016-08-11 |
2018-02-15 |
Genentech, Inc. |
Pyrrolobenzodiazepine prodrugs and antibody conjugates thereof
|
CN110139674B
(en)
|
2016-10-05 |
2023-05-16 |
豪夫迈·罗氏有限公司 |
Method for preparing antibody drug conjugates
|
TWI762516B
(en)
|
2016-10-06 |
2022-05-01 |
日商腫瘤療法 科學股份有限公司 |
Monoclonal antibodies against FZD10 and their uses
|
GB201617466D0
(en)
|
2016-10-14 |
2016-11-30 |
Medimmune Ltd |
Pyrrolobenzodiazepine conjugates
|
TW201839136A
(en)
|
2017-02-06 |
2018-11-01 |
瑞士商諾華公司 |
Compositions and methods for the treatment of hemoglobinopathies
|
GB201702031D0
(en)
|
2017-02-08 |
2017-03-22 |
Medlmmune Ltd |
Pyrrolobenzodiazepine-antibody conjugates
|
JP6671555B2
(en)
|
2017-02-08 |
2020-03-25 |
アーデーセー セラピューティクス ソシエテ アノニム |
Pyrrolobenzodiazepine antibody conjugate
|
AU2018255876B2
(en)
|
2017-04-18 |
2020-04-30 |
Medimmune Limited |
Pyrrolobenzodiazepine conjugates
|
AU2018253948A1
(en)
|
2017-04-20 |
2019-09-19 |
Adc Therapeutics Sa |
Combination therapy with an anti-AXL Antibody-Drug Conjugate
|
MX2019015042A
(en)
|
2017-06-14 |
2020-08-06 |
Adc Therapeutics Sa |
Dosage regimes for the administration of an anti-cd19 adc.
|
KR102270107B1
(en)
|
2017-08-18 |
2021-06-30 |
메디뮨 리미티드 |
pyrrolobenzodiazepine conjugate
|
CN111788208B
(en)
|
2017-09-20 |
2023-11-24 |
Ph制药有限公司 |
Talarstatin analogues
|
GB201803342D0
(en)
|
2018-03-01 |
2018-04-18 |
Medimmune Ltd |
Methods
|
GB201806022D0
(en)
|
2018-04-12 |
2018-05-30 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
GB201814281D0
(en)
|
2018-09-03 |
2018-10-17 |
Femtogenix Ltd |
Cytotoxic agents
|
JP2022505450A
(en)
|
2018-10-24 |
2022-01-14 |
エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト |
Conjugated chemical decomposition inducers and usage
|
CN113227119A
(en)
|
2018-12-10 |
2021-08-06 |
基因泰克公司 |
Photocrosslinked peptides for site-specific conjugation to Fc-containing proteins
|
GB201901197D0
(en)
|
2019-01-29 |
2019-03-20 |
Femtogenix Ltd |
G-A Crosslinking cytotoxic agents
|
GB2597532A
(en)
|
2020-07-28 |
2022-02-02 |
Femtogenix Ltd |
Cytotoxic compounds
|
CN114163510A
(en)
*
|
2021-03-24 |
2022-03-11 |
深圳市新靶向生物科技有限公司 |
Antigenic peptide combination related to liver cancer driver gene mutation and application thereof
|
WO2023217735A1
(en)
*
|
2022-05-13 |
2023-11-16 |
Hummingbird Diagnostics Gmbh |
Novel rna molecule for cancer detection
|